Country

Clinical trials in Denmark

Active obesity and GLP-1 studies with at least one location in Denmark.

85active studies

46recruiting now

33countries represented

187largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Ulcerative Colitis, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium187 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937086See eligibility →

Recruiting nowPhase 3

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Crohn's Disease, Obesity or OverweightCondition

Mirikizumab, MirikizumabTreatment

Austria, Belgium183 locations

Eli Lilly and CompanySponsor

Updated 2026-09-04 · NCT06937099See eligibility →

Recruiting nowPhase 1

A Research Study to See How NNC0487-0111 Affects the Body's Energy Use After a Weight Loss in Adults Living With Obesity, Compared to a Low-calorie Diet or Placebo

Overweight, ObesityCondition

NNC0487-0111, PlaceboTreatment

Denmark, Netherlands2 locations

Novo Nordisk A/SSponsor

Updated 2026-09-02 · NCT07757087See eligibility →

Recruiting nowPhase 3

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Overweight, ObesityCondition

Cagrilintide, SemaglutideTreatment

Australia, Austria121 locations

Novo Nordisk A/SSponsor

Updated 2026-08-31 · NCT07253285See eligibility →

Recruiting nowPhase 3

AMAZE 12: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Maintain Their Weight Loss

ObesityCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Argentina, Australia72 locations

Novo Nordisk A/SSponsor

Updated 2026-08-27 · NCT07503210See eligibility →

Recruiting nowNot applicable

Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial

ObesityCondition

Intensive weight loss intervention, Bariatric surgeryTreatment

Denmark, United Kingdom14 locations

Carsten DirksenSponsor

Updated 2026-08-21 · NCT06309238See eligibility →

Recruiting nowPhase 3

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Overweight, ObesityCondition

Semaglutide, PlaceboTreatment

Belgium, Bulgaria62 locations

Novo Nordisk A/SSponsor

Updated 2026-08-18 · NCT07770841See eligibility →

Recruiting nowPhase 3

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Australia, Bulgaria81 locations

Novo Nordisk A/SSponsor

Updated 2026-08-17 · NCT07509307See eligibility →

Recruiting nowPhase 3

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Obesity, OverweightCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Australia, China80 locations

Novo Nordisk A/SSponsor

Updated 2026-07-13 · NCT07571005See eligibility →

Recruiting nowNot applicable

HALO-TRIAL: High, Medium And LOw Intensity Psychotherapy for Binge Eating Disorder

Binge Eating Disorder, Binge Eating EpisodesCondition

Cognitive Behavioral Therapy Enhanced - Individual, Cognitive Behavioral Therapy Enhanced - GroupTreatment

Denmark1 locations

Herlev and Gentofte HospitalSponsor

Updated 2026-07-13 · NCT07698132See eligibility →

Recruiting nowPhase 3

A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Obesity, Knee Osteoarthritis (OA)Condition

NNC0487-0111, Placebo (matched to NNC0487-0111 )Treatment

Australia, Bulgaria82 locations

Novo Nordisk A/SSponsor

Updated 2026-07-09 · NCT07481630See eligibility →

Recruiting nowPhase 3

AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight

ObesityCondition

NNC0487-0111, Placebo (matched to NNC0487-0111)Treatment

Argentina, Australia72 locations

Novo Nordisk A/SSponsor

Updated 2026-07-09 · NCT07339423See eligibility →

Recruiting nowNot applicable

The Effect of Fasting on Peak Fat Oxidation, Mitochondrial Coupling and Extracellular Matrix

Fasting, Obesity (BMI>30)Condition

DietTreatment

Denmark1 locations

University of CopenhagenSponsor

Updated 2026-07-09 · NCT07692646See eligibility →

Recruiting nowNot applicable

When to INDuce for OverWeight? (WINDOW)

Pregnancy, ObesityCondition

Elective induction of labor at 39 gestational weeks and 0 to 3 daysTreatment

Denmark12 locations

University of AarhusSponsor

Updated 2026-06-26 · NCT04603859See eligibility →

Recruiting nowPhase 2, Phase 3

Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure

Heart Failure With Reduced Ejection Fraction, ObesityCondition

Semaglutide Injectable Product, Calorie-restricted dietTreatment

Denmark1 locations

Jens D Hove, MD,PHDSponsor

Updated 2026-06-23 · NCT06423599See eligibility →

Recruiting nowPhase 2

Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder

Cannabis Use Disorder, Cannabis Use DisordersCondition

semaglutide, PlaceboTreatment

Denmark1 locations

Anders Fink-Jensen, MD, DMSciSponsor

Updated 2026-05-14 · NCT07523633See eligibility →

Recruiting nowPhase 3

Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients

Foot Ulcer Due to Type 2 Diabetes MellitusCondition

Semaglutide, 1.34 mg/mL, PlaceboTreatment

Denmark1 locations

Ole Lander SvendsenSponsor

Updated 2026-05-12 · NCT07581145See eligibility →

Recruiting nowPhase 1

Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)

ObesityCondition

Cagrilintide, SemaglutideTreatment

Denmark1 locations

Novo Nordisk A/SSponsor

Updated 2026-05-07 · NCT07527195See eligibility →

Recruiting nowNot applicable

Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy Humans

Obesity & OverweightCondition

Amylin (Pramlintide), Pancreatic Polypeptide (PP)Treatment

Denmark1 locations

University Hospital, Gentofte, CopenhagenSponsor

Updated 2026-04-01 · NCT07506369See eligibility →

Recruiting nowNot applicable

Physical Inactivity and Appetite Regulation

OverweightCondition

InactivityTreatment

Denmark1 locations

Rigshospitalet, DenmarkSponsor

Updated 2026-03-30 · NCT06240208See eligibility →

Recruiting nowNot applicable

The Metabolic Effects of Oral Tributyrin Administration

Healthy Overweight/ObeseCondition

tributyrin, ControlTreatment

Denmark1 locations

University of AarhusSponsor

Updated 2026-03-16 · NCT07463495See eligibility →

Recruiting nowNot applicable

Cortisol and Obesity - A Vicious Cycle? Hypoglycemia After Bariatric Surgery - Association With Cortisol Metabolism?

Postbariatric HypoglycemiaCondition

Intervention not listedTreatment

Denmark1 locations

Esbjerg Hospital - University Hospital of Southern DenmarkSponsor

Updated 2026-03-13 · NCT06896682See eligibility →

Recruiting nowPhase 2

Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use Disorder

Alcohol Use Disorder, Alcohol Abuse/DependenceCondition

Tirzepatide, PlaceboTreatment

Denmark2 locations

Anders Fink-Jensen, MD, DMSciSponsor

Updated 2026-02-10 · NCT06939088See eligibility →

Recruiting nowPhase 4

Does Semaglutide Improve Depressive Symptoms in Patients With Major Depressive Disorder and Overweight or Obesity

Major Depressive DisorderCondition

Semaglutide Injectable Product, PlaceboTreatment

Denmark1 locations

Nordsjaellands HospitalSponsor

Updated 2026-02-06 · NCT07136714See eligibility →

Recruiting nowNot applicable

Effects of Ketone Bodies on Insulin Sensitivity

Insulin Resistance, Obesity & OverweightCondition

Growth Hormone, Human, Oral ketone supplement (KetoAid®, KE4)Treatment

Denmark1 locations

University of AarhusSponsor

Updated 2026-01-22 · NCT07359625See eligibility →

Recruiting nowNot applicable

Glucose-dependent INsulinotropic Polypeptide: Effect on Bone Remodelling and Cell Activity (GINEBRA)

Bone Disease, Metabolic, Diabetes Mellitus, Type 2Condition

Glucose-dependent Insulinotropic Polypeptide (GIP)Treatment

Denmark1 locations

Esbjerg Hospital - University Hospital of Southern DenmarkSponsor

Updated 2026-01-02 · NCT06790225See eligibility →

Recruiting nowPhase 4

Semaglutide Treatment for Hyperglycaemia After Renal Transplantation

Hyperglycemia, Renal Transplant Complication Primary Non-FunctionCondition

Semaglutide 14 MG [Rybelsus], PlaceboTreatment

Denmark1 locations

Rigshospitalet, DenmarkSponsor

Updated 2025-12-29 · NCT05702931See eligibility →

Recruiting nowNot applicable

The Bloom Study - a Safe and Healthy Start in Life

Overweight, Childhood, Obesity in ChildrenCondition

Multi-behaviouralTreatment

Denmark1 locations

University of Southern DenmarkSponsor

Updated 2025-12-22 · NCT06705400See eligibility →

Recruiting nowNot applicable

Effect of Sleep Extension on Body Weight and Learning in Children (More2Sleep)

Sleep Duration, Child ObesityCondition

Sleep extensionTreatment

Denmark3 locations

University of CopenhagenSponsor

Updated 2025-11-25 · NCT06341179See eligibility →

Recruiting nowPhase 4

A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease

Chronic Kidney Disease(CKD)Condition

Dapagliflozin, SemaglutideTreatment

Denmark, Germany4 locations

Peter RossingSponsor

Updated 2025-11-20 · NCT07239570See eligibility →

Recruiting nowNot applicable

LiPO Teen (the Lifestyle in Pregnancy and Offspring Teenagers

Obesity, Life Style, HealthyCondition

Lifestyle intervention Dietary advise and/or advise on physical activityTreatment

Denmark1 locations

Odense University HospitalSponsor

Updated 2025-11-19 · NCT05774652See eligibility →

Recruiting nowPhase 1, Phase 2

Studying the Influence of LEAP2 on Integrated Endocrine Control of Eating During Semaglutide Treatment

Obesity &Amp; OverweightCondition

Liver-Expressed Antimicrobial Peptide 2 (LEAP2), Placebo (saline)Treatment

Denmark1 locations

University Hospital, Gentofte, CopenhagenSponsor

Updated 2025-09-18 · NCT07171723See eligibility →

Recruiting nowPhase 1

The Role of the Amylin Analogue Cagrilintide in Bone Metabolism

ObesityCondition

Cagrilintide, SemaglutideTreatment

Denmark1 locations

Novo Nordisk A/SSponsor

Updated 2025-07-25 · NCT07010432See eligibility →

Recruiting nowNot applicable

Depletion of Liver Fat in Type 2 Diabetes

Type2diabetes, ObesityCondition

Very-low calorie dietTreatment

Denmark1 locations

Rigshospitalet, DenmarkSponsor

Updated 2025-07-22 · NCT06211556See eligibility →

Recruiting nowPhase 4

The Effects of Tirzepatide in People With Overweight/Obesity and Coronary Artery Disease

Coronary Artery Disease, Coronary Microvascular DysfunctionCondition

Tirzepatide, PlaceboTreatment

Denmark3 locations

Tina VilsbøllSponsor

Updated 2025-05-22 · NCT06606821See eligibility →

Recruiting nowNot applicable

Holbæk Obesity Treatment (HOT) Versus Conventional Obesity Treatment (COT) in Children With Overweight or Obesity.

Childhood Overweight and ObesityCondition

Holbæk Obesity Treatment, Conventional Obesity TreatmentTreatment

Denmark5 locations

Holbaek SygehusSponsor

Updated 2025-04-20 · NCT05038683See eligibility →

Recruiting nowNot applicable

Prognostic Significance of Fatty Liver Disease in Bariatric Patients

Non-Alcoholic Fatty Liver Disease, Metabolic EncephalopathyCondition

Bariatric surgeryTreatment

Denmark1 locations

Esbjerg Hospital - University Hospital of Southern DenmarkSponsor

Updated 2025-03-05 · NCT03535142See eligibility →

Recruiting nowPhase 2

Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis

Osteoarthritis in the Knee, ObesityCondition

KBP-336, PlaceboTreatment

Czechia, Denmark20 locations

KeyBioscience AGSponsor

Updated 2025-02-19 · NCT06833749See eligibility →

Recruiting nowNot applicable

Inflammation's Impact on Heart Disease and Diabetes

Inflammation, Obesity and Type 2 DiabetesCondition

Gastric bypassTreatment

Denmark1 locations

University of AarhusSponsor

Updated 2025-02-03 · NCT06752018See eligibility →

Recruiting nowPhase 4

A Study Investigating Oral Semaglutide in People with Open-Angle Glaucoma

Primary Open Angle Glaucoma (POAG), Open-Angle GlaucomaCondition

Oral semaglutide, PlaceboTreatment

Denmark1 locations

Glostrup University Hospital, CopenhagenSponsor

Updated 2025-01-24 · NCT06792422See eligibility →

Recruiting nowPhase 3

Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes

Cardiovascular Diseases, Heart FailureCondition

Aspirin tablet, SemaglutideTreatment

Denmark2 locations

Steno Diabetes Center CopenhagenSponsor

Updated 2025-01-10 · NCT06082063See eligibility →

Recruiting nowNot applicable

Inflammatory Resolution in Cardiometabolic Health and Disease

Inflammation, ObesityCondition

Intervention not listedTreatment

Denmark1 locations

University of AarhusSponsor

Updated 2024-06-28 · NCT06390189See eligibility →

Recruiting nowNot applicable

PRE-Pregnancy Weight Loss And the Reducing Effect on CHILDhood Overweight - Aarhus

Overweight and Obesity, Weight LossCondition

Weight loss interventionTreatment

Denmark1 locations

Ulla Kampmann OpstrupSponsor

Updated 2024-01-18 · NCT05798494See eligibility →

Recruiting nowNot applicable

South Danish Obesity Initiative, Screening for Unrecognized Obesity Related Disease

ObesityCondition

Life style intervention (dietician+ physiotherapist), Self managementTreatment

Denmark1 locations

Claus Bogh JuhlSponsor

Updated 2023-10-19 · NCT05176132See eligibility →

Recruiting nowPhase 2

Acute Subcutaneous SemaglutidE in Acute Ischemic sTroke

Acute Ischemic StrokeCondition

Semaglutide, Standard careTreatment

Denmark1 locations

Aarhus University HospitalSponsor

Updated 2023-04-25 · NCT05630586See eligibility →

Recruiting nowNot applicable

Insulin Sensitivity After Breast Cancer

Insulin Sensitivity/Resistance, Breast CancerCondition

InsulinTreatment

Denmark1 locations

University of CopenhagenSponsor

Updated 2021-08-18 · NCT05010356See eligibility →

Opening soonNot applicable

A Retrospective Real-World Cohort Study

Obesity, Type 2 Diabetes (T2D)Condition

No treatment givenTreatment

Denmark1 locations

Novo Nordisk A/SSponsor

Updated 2026-08-24 · NCT07781371See eligibility →

Opening soonPhase 3

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Obesity or Overweight, Weight-Related ComorbidityCondition

AZD6234, PlaceboTreatment

Argentina, Brazil88 locations

AstraZenecaSponsor

Updated 2026-08-20 · NCT07776509See eligibility →

Opening soonNot applicable

The Role of Autoantibodies Against G-protein Coupled Receptors in Obesity

Obesity, Obesity & OverweightCondition

Intervention not listedTreatment

Denmark1 locations

Claus Bogh JuhlSponsor

Updated 2026-04-24 · NCT07542327See eligibility →

Opening soonNot applicable

Effectiveness of a 10-week Multicomponent Intervention Combined With Parent Education on Binge Eating Behavior in Children and Adolescents

Binge Eating Disorder, Binge EatingCondition

A 10-week multicomponent camp intervention for children, A BED intervention for parentsTreatment

Denmark2 locations

University of AarhusSponsor

Updated 2026-04-13 · NCT07301541See eligibility →

Opening soonPhase 2

Biased GRK Signaling Via β2-Adrenergic Receptors in Human Skeletal Muscle

Overweight and ObesityCondition

ATR-258Treatment

Denmark1 locations

Morten Hostrup, PhDSponsor

Updated 2026-02-19 · NCT07421024See eligibility →

Opening soonPhase 3

Semaglutide Treatment in Type 1 Diabetes

Obesity in Diabetes, Obesity/TherapyCondition

Semaglutide 2.4mg, Semaglutide placeboTreatment

Denmark1 locations

Nordsjaellands HospitalSponsor

Updated 2025-08-08 · NCT06909006See eligibility →

Opening soonNot applicable

Empowering Healthy Lifestyle Personalised Intervention to Prevent and Control Obesity: The HealthyW8 Project

Obesity Prevention, Obesity and OverweightCondition

Intervention GroupTreatment

Bulgaria, Denmark13 locations

Fundació d'investigació Sanitària de les Illes BalearsSponsor

Updated 2025-07-01 · NCT07011368See eligibility →

Opening soonNot applicable

Improvements in Daily Activity and Exercise in School Children: the ActChild Study

Healthy Children, ChildrenCondition

ExerciseTreatment

Denmark1 locations

University of AarhusSponsor

Updated 2025-01-24 · NCT06791278See eligibility →

Invitation onlyPhase 4

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

Type 2 DM, Type 2 DM /Diabetic NephropathyCondition

Semaglutide, 1.34 mg/mL, Finerenone Oral TabletTreatment

Denmark1 locations

Steno Diabetes Center CopenhagenSponsor

Updated 2025-12-22 · NCT06954090See eligibility →

Invitation onlyNot applicable

Transcriptional Changes in Isolated Human Adipocytes During Obesity

Obesity, Abdominal, AdiposityCondition

Intervention not listedTreatment

Denmark1 locations

University of Southern DenmarkSponsor

Updated 2025-04-02 · NCT06907212See eligibility →

Invitation onlyNot applicable

Skeletal Maturation and Endocrine Health in Young Adults

Osteoporosis, SarcopeniaCondition

Intervention not listedTreatment

Denmark9 locations

Holbaek SygehusSponsor

Updated 2025-01-10 · NCT06509776See eligibility →

Invitation onlyNot applicable

A Weight-Neutral Approach for a Healthier Lifestyle Among Obesity - A Lifestyle Intervention Anchored in SDOI

Health Related Quality of Life and Weight ConditionCondition

Lifestyle Intervention, PlaceboTreatment

Denmark1 locations

Esbjerg Hospital - University Hospital of Southern DenmarkSponsor

Updated 2024-09-26 · NCT05708417See eligibility →

Invitation onlyNot applicable

Twenty-year Follow-up of the Inter99 Cohort

Coronary Heart Disease, Acute Myocardial InfarctionCondition

Intervention not listedTreatment

Denmark1 locations

Bispebjerg HospitalSponsor

Updated 2024-02-28 · NCT05166447See eligibility →

Active, not recruitingNot applicable

Intensive Weight Loss Intervention Versus Usual Care for Adults With Severe and Complex Obesity

ObesityCondition

Intensive weight loss intervention, Usual careTreatment

Denmark, United Kingdom14 locations

Carsten DirksenSponsor

Updated 2026-08-24 · NCT06321458See eligibility →

This page shows the first 60 studies. Use the full search to filter all matches.

Related countries

United States1,107 China326 Canada158 France110 Spain98 Germany95

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.